Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.

[1]  D. Talwar,et al.  Plasma dimethylarginines during the acute inflammatory response , 2011, European journal of clinical investigation.

[2]  Xinli Hu,et al.  Vascular Endothelial-Specific Dimethylarginine Dimethylaminohydrolase-1–Deficient Mice Reveal That Vascular Endothelium Plays an Important Role in Removing Asymmetric Dimethylarginine , 2009, Circulation.

[3]  F. Palm,et al.  Cellular ADMA: regulation and action. , 2009, Pharmacological research.

[4]  Yong Xia,et al.  Role of Dimethylarginine Dimethylaminohydrolases in the Regulation of Endothelial Nitric Oxide Production* , 2009, The Journal of Biological Chemistry.

[5]  D. Tsikas,et al.  The L-arginine/NO pathway in end-stage liver disease and during orthotopic liver and kidney transplantation: biological and analytical ramifications. , 2009, Nitric oxide : biology and chemistry.

[6]  Zhaoguang Liang,et al.  Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs. , 2008, Biochemical and biophysical research communications.

[7]  M. Siroen,et al.  The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function. , 2008, JPEN. Journal of parenteral and enteral nutrition.

[8]  G. Van den Berghe,et al.  Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. , 2008, Endocrinology.

[9]  Dan Wang,et al.  Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  Maristela L Onozato,et al.  Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. , 2007, American journal of physiology. Heart and circulatory physiology.

[11]  Maristela L Onozato,et al.  Isoform-Specific Regulation by NG,NG-Dimethylarginine Dimethylaminohydrolase of Rat Serum Asymmetric Dimethylarginine and Vascular Endothelium-Derived Relaxing Factor/NO , 2007, Circulation research.

[12]  D. Wilcken,et al.  Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism. , 2007, Molecular genetics and metabolism.

[13]  KoichiroHomma,et al.  Role of Asymmetric Dimethylarginine in Vascular Injury in Transgenic Mice Overexpressing Dimethylarginie Dimethylaminohydrolase 2 , 2007 .

[14]  K. Homma,et al.  Role of Asymmetric Dimethylarginine in Vascular Injury in Transgenic Mice Overexpressing Dimethylarginie Dimethylaminohydrolase 2 , 2007, Circulation research.

[15]  T. Teerlink,et al.  HPLC analysis of ADMA and other methylated L-arginine analogs in biological fluids. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  Roger Williams,et al.  Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  P. Vallance,et al.  Disruption of methylarginine metabolism impairs vascular homeostasis , 2007, Nature Medicine.

[18]  J. Zweier,et al.  Evidence for the Pathophysiological Role of Endogenous Methylarginines in Regulation of Endothelial NO Production and Vascular Function* , 2007, Journal of Biological Chemistry.

[19]  Roger Williams,et al.  Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis , 2007, Hepatology.

[20]  F. Grimminger,et al.  Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[21]  H. Prins,et al.  The clinical significance of asymmetric dimethylarginine. , 2006, Annual review of nutrition.

[22]  T. Teerlink,et al.  Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. , 2006, Analytical biochemistry.

[23]  H. Katus,et al.  Expression of nitric oxide related enzymes in coronary heart disease , 2006, Basic Research in Cardiology.

[24]  R. Nijveldt,et al.  No Compensatory Upregulation of Placental Dimethylarginine Dimethylaminohydrolase Activity in Preeclampsia , 2006, Gynecologic and Obstetric Investigation.

[25]  S. Moncada,et al.  The discovery of nitric oxide and its role in vascular biology , 2006, British journal of pharmacology.

[26]  Xin Xu,et al.  Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts. , 2005, American journal of physiology. Heart and circulatory physiology.

[27]  T. Teerlink.  ADMA metabolism and clearance , 2005, Vascular medicine.

[28]  R. Nijveldt,et al.  The human liver clears both asymmetric and symmetric dimethylarginine , 2005, Hepatology.

[29]  G. Van den Berghe,et al.  Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: A possible explanation of reduced morbidity and mortality?* , 2005, Critical care medicine.

[30]  E. Kuipers,et al.  The transplanted liver graft is capable of clearing asymmetric dimethylarginine , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  M. Cuesta,et al.  Elevation of asymmetric dimethylarginine (ADMA) in patients developing hepatic failure after major hepatectomy. , 2004, JPEN. Journal of parenteral and enteral nutrition.

[32]  M. Serra,et al.  Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis. , 2004, Journal of hepatology.

[33]  P. Tsao,et al.  Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis: Genetic and Physiological Evidence , 2003, Circulation.

[34]  H. Prins,et al.  Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  R. Johns,et al.  Evidence for Dysregulation of Dimethylarginine Dimethylaminohydrolase I in Chronic Hypoxia–Induced Pulmonary Hypertension , 2003, Circulation.

[36]  P. Vallance,et al.  Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[37]  T. Teerlink,et al.  Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality , 2003, Clinical nutrition.

[38]  R. Nijveldt,et al.  The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). , 2003, Clinical nutrition.

[39]  N. Chan,et al.  Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? , 2002, Diabetologia.

[40]  C. Stehouwer,et al.  Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[41]  P. Tsao,et al.  Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase , 2002, Circulation.

[42]  R. Nijveldt,et al.  Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. , 2002, Analytical biochemistry.

[43]  W. Schlack,et al.  Myocardial proteome analysis reveals reduced NOS inhibition and enhanced glycolytic capacity in areas of low local blood flow , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  P. Tsao,et al.  Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. , 2002, JAMA.

[45]  T. Hardy,et al.  Coordinate regulation of L-arginine uptake and nitric oxide synthase activity in cultured endothelial cells. , 2002, Free radical biology & medicine.

[46]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[47]  D. Fliser,et al.  Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[48]  J P Cooke,et al.  Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. , 2001, The American journal of cardiology.

[49]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[50]  R. D'Hooge,et al.  N G , N G -Dimethylarginine and N G , N ' G -dimethylarginine in renal insufficiency , 2000 .

[51]  R. D'Hooge,et al.  NG,NG-Dimethylarginine and NG,N'G-dimethylarginine in renal insufficiency , 2000, Pflügers Archiv.

[52]  E. Block,et al.  A Caveolar Complex between the Cationic Amino Acid Transporter 1 and Endothelial Nitric-oxide Synthase May Explain the “Arginine Paradox”* , 1997, The Journal of Biological Chemistry.

[53]  M. Clark,et al.  Role of blood flow in the regulation of muscle glucose uptake. , 1997, Annual review of nutrition.

[54]  P. V. van Leeuwen,et al.  Plasma amino acids determined by liquid chromatography within 17 minutes. , 1994, Clinical chemistry.

[55]  S. Moncada,et al.  Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure , 1992, The Lancet.

[56]  M. Lou.  Human muscular dystrophy: elevation of urinary dimethylarginines. , 1979, Science.

[57]  J. Mcdermott,et al.  Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit. , 1976, The Biochemical journal.